4/13/2010

Johnson & Johnson's Cordis unit has begun a nonrandomized trial designed to test the ability of its Incraft stent in treating patients with abdominal aortic aneurysm. The device features an ultra-low-profile delivery system and can be tailored to an individual patient during implantation.

Related Summaries